Y-mAbs Therapeutics
YMAB
#6603
Rank
$0.51 B
Marketcap
$11.59
Share price
-12.06%
Change (1 day)
137.50%
Change (1 year)

Y-mAbs Therapeutics (YMAB) - Total liabilities

Total liabilities on the balance sheet as of June 2024 : $48.69 Million USD

According to Y-mAbs Therapeutics 's latest financial reports the company's total liabilities are $48.69 Million USD. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Y-mAbs Therapeutics - Total liabilities on balance sheet (from 2017 to 2024)

Total liabilities by year

Year Total liabilities Change
2023-12-31$26.88 M-16.6%
2022-12-31$32.23 M-1.35%
2021-12-31$32.67 M24.67%
2020-12-31$26.21 M50.09%
2019-12-31$17.46 M53.22%
2018-12-31$11.39 M14.26%
2017-12-31$9.97 M91.83%
2016-12-31$5.2 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
$26.5 M-45.57%๐Ÿ‡บ๐Ÿ‡ธ USA